List view / Grid view

Pfizer

 

news

Allergan and Pfizer terminate merger agreement

6 April 2016 | By Victoria White

The decision was driven by the actions announced by the US Department of Treasury to reform inversion tax rules, which the companies concluded qualified as an “Adverse Tax Law Change”. Market rumour suggests that Pfizer will now target Shire or AstraZeneca and shares in both companies went up with the…

news

Pfizer joins the Human Vaccines Project

22 March 2016 | By Victoria White

The Human Vaccines Project is focused on cross-sector collaboration to identify human immune responses associated with optimal vaccine protection...

news

Pfizer expands its R&D investment strategy

12 January 2016 | By Victoria White

The first four investments of the newly focused initiative include $46 million in financing to companies at early stages of the discovery process that are actively exploring Conditionally Active Biologics (CABs), immuno-oncology, neurodegenerative technologies and gene therapy...

news

Heptares and Pfizer to focus on GPCR targets

30 November 2015 | By Victoria White

Heptares and Pfizer have announced they are to research and develop potential new medicines directed at up to 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic areas...